Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,975.80
+25.60 (1.31%)
Aug 14, 2025, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 325.53 billion as of August 15, 2025. Its market cap has decreased by -4.02% in one year.
Market Cap
325.53B
Enterprise Value
299.14B
Revenue
57.20B
Ranking
n/a
PE Ratio
42.26
Stock Price
1,975.80
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 325.53B, an increase of 9.57%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 325.53B | 11.04% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,934.43B |
| Divi's Laboratories | 1,619.49B |
| Cipla | 1,260.90B |
| Apollo Hospitals Enterprise | 1,122.74B |
| Mankind Pharma | 1,017.79B |
| Zydus Lifesciences | 994.76B |
| Fortis Healthcare | 714.04B |
| Alkem Laboratories | 644.28B |